EA202191001A1 - Соединения для лечения аренавирусной инфекции - Google Patents

Соединения для лечения аренавирусной инфекции

Info

Publication number
EA202191001A1
EA202191001A1 EA202191001A EA202191001A EA202191001A1 EA 202191001 A1 EA202191001 A1 EA 202191001A1 EA 202191001 A EA202191001 A EA 202191001A EA 202191001 A EA202191001 A EA 202191001A EA 202191001 A1 EA202191001 A1 EA 202191001A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
compounds
arenaviral
infection
arenavirus
Prior art date
Application number
EA202191001A
Other languages
English (en)
Russian (ru)
Inventor
Эрик Браун
Видиасагар Редди Гантла
Надежда Соколова
Майкл Бруно Плю
Грэгори Хенкел
Кеннет Маккормак
Original Assignee
Арисен Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арисен Терапьютикс, Инк. filed Critical Арисен Терапьютикс, Инк.
Publication of EA202191001A1 publication Critical patent/EA202191001A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA202191001A 2018-12-06 2019-12-03 Соединения для лечения аренавирусной инфекции EA202191001A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862776390P 2018-12-06 2018-12-06
PCT/US2019/064223 WO2020117794A1 (en) 2018-12-06 2019-12-03 Compounds for the treatment of arenavirus infection

Publications (1)

Publication Number Publication Date
EA202191001A1 true EA202191001A1 (ru) 2021-08-16

Family

ID=70975517

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191001A EA202191001A1 (ru) 2018-12-06 2019-12-03 Соединения для лечения аренавирусной инфекции

Country Status (9)

Country Link
EP (1) EP3890731A4 (cg-RX-API-DMAC7.html)
JP (1) JP7675009B2 (cg-RX-API-DMAC7.html)
CN (1) CN113329750B (cg-RX-API-DMAC7.html)
AR (1) AR117228A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019393784B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021010909A2 (cg-RX-API-DMAC7.html)
EA (1) EA202191001A1 (cg-RX-API-DMAC7.html)
MX (2) MX2021005234A (cg-RX-API-DMAC7.html)
WO (1) WO2020117794A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116217490B (zh) * 2023-02-03 2025-09-26 中国人民解放军军事科学院军事医学研究院 一种苯并咪唑类化合物及其制备方法和应用
EP4434972A1 (en) * 2023-03-22 2024-09-25 Eberhard-Karls-Universität Tübingen Atm kinase inhibitors
AU2024409086A1 (en) * 2023-12-20 2026-08-06 Arisan Therapeutics Inc. Crystalline forms of an imidazopyridine derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100477070B1 (ko) * 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
WO2012065297A1 (en) * 2010-11-16 2012-05-24 Impact Therapeutics, Inc. 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
MX359989B (es) * 2012-02-17 2018-10-18 Siga Tech Inc Fármacos antivirales para el tratamiento de la infección por arenavirus.
US9688680B2 (en) 2014-08-04 2017-06-27 Blueprint Medicines Corporation Compositions useful for treating disorders related to kit
US11352328B2 (en) * 2016-07-12 2022-06-07 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus

Also Published As

Publication number Publication date
JP2022509763A (ja) 2022-01-24
JP7675009B2 (ja) 2025-05-12
MX2021005234A (es) 2021-08-11
KR20210106997A (ko) 2021-08-31
AU2019393784A1 (en) 2021-05-27
BR112021010909A2 (pt) 2021-08-24
CN113329750A (zh) 2021-08-31
WO2020117794A1 (en) 2020-06-11
EP3890731A4 (en) 2022-08-17
MX2024013042A (es) 2024-12-06
AU2019393784B2 (en) 2025-06-12
CA3118765A1 (en) 2020-06-11
AR117228A1 (es) 2021-07-21
EP3890731A1 (en) 2021-10-13
CN113329750B (zh) 2025-10-17

Similar Documents

Publication Publication Date Title
JOP20180123A1 (ar) مركبات علاجية مفيدة للوقاية من أو علاج الإصابة بفيروس نقص المناعة البشرية
LT4445900T (lt) Terapiniai junginiai, skirti živ viruso infekcijai gydyti
EP4157272C0 (en) REMDESIVIR FOR THE TREATMENT OF VIRAL INFECTIONS
IL289655A (en) Compounds useful to treat influenza virus infections
EA201890735A1 (ru) Модуляторы корового белка вируса гепатита b
IL290792A (en) Compositions and methods for the treatment of viral infections
EA202090693A1 (ru) Новый ингибитор mek для лечения вирусных и бактериальных инфекций
EA201592126A1 (ru) 6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
DOP2019000225A (es) Compuestos sulfamida cíclicos y métodos de uso de los mismos
EA201791886A1 (ru) Антивирусные соединения
EP3577118C0 (en) COMPOUNDS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION
EA201691726A1 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
EA201790630A1 (ru) Способы получения рибозидов
MX2021016149A (es) Inhibidores de la replicacion del virus de inmunodeficiencia humana.
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
PE20191461A1 (es) Compuestos amida para el tratamiento del vih
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
EA202092171A1 (ru) Схема дозирования модулятора сборки капсида
MX2024013042A (es) Compuestos para el tratamiento de la infeccion por arenavirus.
JOP20200326A1 (ar) مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها
EA201890818A1 (ru) Режим комбинированной терапии для лечения hcv
EA201892375A1 (ru) Способы лечения инфекций, вызываемых вирусом гепатита b
EA201992233A1 (ru) Соединения изоксазолкарбоксамида и их применение
EA202190590A1 (ru) Соединения и способы лечения грибковых инфекций